Plain-English translation of NCT07277660 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help adults with moderate-to-severe eczema. Researchers want to find the right dose of the medication by comparing it to a placebo (a dummy pill with no medicine). The study will follow you for about 16 weeks initially, then continue longer to see how well this treatment works and how safe it is.
Many people with severe eczema don't get enough relief from topical creams and lotions alone. This trial is looking for a new systemic treatment option that could help patients whose eczema significantly impacts their quality of life.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication or a placebo pill at different dose levels. You'll take your assigned treatment for 16 weeks, with visits to the clinic to check how your skin is improving and monitor for any side effects. After week 16, you may continue on the same dose or have it adjusted based on how you're responding. The study tracks your eczema severity, itching, and overall skin improvement throughout the trial period.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States